Rationale for percutaneous biopsy and histologic characterisation of renal tumours

European Urology

Volumn 62, Issue 3, 2012, Pages 491-504

  Volpe, Alessandro ^a   Finelli, Antonio ^b   Gill, Inderbir S ^c   Jewett, Michael A S ^b   Martignoni, Guido ^d   Polascik, Thomas J ^e   Remzi, Mesut ^f   Uzzo, Robert G ^g  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF VERONA   (Italy)

^e DUKE CANCER INSTITUTE   (United States)

^f Landesklinikum Weinviertel Korneuburg ^*  (Austria)

^g FOX CHASE CANCER CENTER   (United States)

Author keywords

Cytogenetic markers; Diagnosis; Molecular markers; Needle core biopsy; Prognosis; Renal cell carcinoma; Renal mass

Indexed keywords

ASPIRATION BIOPSY; BLADDER CANCER; CANCER RISK; CLINICAL PRACTICE; EMBASE; GENE EXPRESSION PROFILING; GENETIC TRAIT; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY CARCINOMA; MEDICAL DECISION MAKING; MEDLINE; MINIMALLY INVASIVE PROCEDURE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; RENAL TUMOR PERCUTANEOUS BIOPSY; REVIEW; SURGICAL RISK; TREATMENT INDICATION; TUMOR BIOPSY; TUMOR LOCALIZATION;

BIOPSY; DECISION SUPPORT TECHNIQUES; HUMANS; KIDNEY; KIDNEY NEOPLASMS; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84864471880     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.05.009     Document Type: Review

References (112)

1. B. Ljungberg, S.C. Campbell, and H.Y. Cho The epidemiology of renal cell carcinoma Eur Urol 60 2011 615 621
2. C.J. Kane, K. Mallin, J. Ritchey, M.R. Cooperberg, and P.R. Carroll Renal cell cancer stage migration: analysis of the National Cancer Data Base Cancer 113 2008 78 83
3. B. Ljungberg, N.C. Cowan, and D.C. Hanbury EAU guidelines on renal cell carcinoma: the 2010 update Eur Urol 58 2010 398 406
4. S.C. Campbell, A.C. Novick, and A. Belldegrun Guideline for management of the clinical T1 renal mass J Urol 182 2009 1271 1279
5. I.S. Gill, M. Aron, D.A. Gervais, and M.A. Jewett Clinical practice. Small renal mass N Engl J Med 362 2010 624 634
6. B.R. Herts, and M.E. Baker The current role of percutaneous biopsy in the evaluation of renal masses Semin Urol Oncol 13 1995 254 261
7. A. Liberati, D.G. Altman, and J. Tetzlaff The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration PLoS Med 6 2009 e1000100
8. Y. Neuzillet, E. Lechevallier, M. Andre, L. Daniel, and C. Coulange Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses J Urol 171 2004 1802 1805
9. B.A. Shannon, R.J. Cohen, H. de Bruto, and R.J. Davies The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses J Urol 180 2008 1257 1261 discussion 1261
10. J. Schmidbauer, M. Remzi, and M. Memarsadeghi Diagnostic accuracy of computed tomography-guided percutaneous biopsy of renal masses Eur Urol 53 2008 1003 1012
11. T. Lebret, J.E. Poulain, and V. Molinie Percutaneous core biopsy for renal masses: indications, accuracy and results J Urol 178 2007 1184 1188 discussion 1188
12. K.E. Maturen, H.V. Nghiem, E.M. Caoili, E.G. Higgins, J.S. Wolf Jr., and D.P. Wood Jr. Renal mass core biopsy: accuracy and impact on clinical management AJR Am J Roentgenol 188 2007 563 570
13. A. Volpe, K. Mattar, and A. Finelli Contemporary results of percutaneous biopsy of 100 small renal masses: a single center experience J Urol 180 2008 2333 2337
14. R. Wang, J.S. Wolf Jr., D.P. Wood Jr., E.J. Higgins, and K.S. Hafez Accuracy of percutaneous core biopsy in management of small renal masses Urology 73 2009 586 590 discussion 590-1
15. A. Veltri, I. Garetto, and I. Tosetti Diagnostic accuracy and clinical impact of imaging-guided needle biopsy of renal masses. Retrospective analysis on 150 cases Eur Radiol 21 2011 393 401
16. M.J. Leveridge, A. Finelli, and J.R. Kachura Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy Eur Urol 60 2011 578 584
17. A. Volpe, J.R. Kachura, and W.R. Geddie Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy J Urol 178 2007 379 386
18. C.B. Dechet, H. Zincke, and T.J. Sebo Prospective analysis of computerized tomography and needle biopsy with permanent sectioning to determine the nature of solid renal masses in adults J Urol 169 2003 71 74
19. S.C. Campbell, A.C. Novick, and B. Herts Prospective evaluation of fine needle aspiration of small, solid renal masses: accuracy and morbidity Urology 50 1997 25 29
20. B.R. Lane, M.K. Samplaski, B.R. Herts, M. Zhou, A.C. Novick, and S.C. Campbell Renal mass biopsy - a renaissance? J Urol 179 2008 20 27
21. H. Wunderlich, W. Hindermann, A.M. Al Mustafa, O. Reichelt, K. Junker, and J. Schubert The accuracy of 250 fine needle biopsies of renal tumors J Urol 174 2005 44 46
22. L.D. Truong, T.D. Todd, B. Dhurandhar, and I. Ramzy Fine-needle aspiration of renal masses in adults: analysis of results and diagnostic problems in 108 cases Diagn Cytopathol 20 1999 339 349
23. I.M. Zardawi Renal fine needle aspiration cytology Acta Cytol 43 1999 184 190
24. B.J. Wood, M.A. Khan, F. McGovern, M. Harisinghani, P.F. Hahn, and P.R. Mueller Imaging guided biopsy of renal masses: indications, accuracy and impact on clinical management J Urol 161 1999 1470 1474
25. Barwari K, Kummerlin IP, Ten Kate FJ, et al. What is the added value of combined core biopsy and fine needle aspiration in the diagnostic process of renal tumours? World J Urol. In press. http://dx.doi.org/10.1007/s00345-011- 0703-2.
26. G.E. Parks, L.A. Perkins, R.J. Zagoria, A.J. Garvin, S.J. Sirintrapun, and K.R. Geisinger Benefits of a combined approach to sampling of renal neoplasms as demonstrated in a series of 351 cases Am J Surg Pathol 35 2011 827 835
27. E.K. Lang, R.J. Macchia, and B. Gayle CT-guided biopsy of indeterminate renal cystic masses (Bosniak 3 and 2F): accuracy and impact on clinical management Eur Radiol 12 2002 2518 2524
28. M.G. Harisinghani, M.M. Maher, and D.A. Gervais Incidence of malignancy in complex cystic renal masses (Bosniak category III): should imaging-guided biopsy precede surgery? AJR Am J Roentgenol 180 2003 755 758
29. F.J. Rybicki, K.M. Shu, E.S. Cibas, J.R. Fielding, E. van Sonnenberg, and S.G. Silverman Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses AJR Am J Roentgenol 180 2003 1281 1287
30. R. Wang, A.Y. Li, and D.P. Wood Jr. The role of percutaneous renal biopsy in the management of small renal masses Curr Urol Rep 12 2011 18 23
31. A. Breda, S.V. Stepanian, and J.S. Lam Use of haemostatic agents and glues during laparoscopic partial nephrectomy: a multi-institutional survey from the United States and Europe of 1347 cases Eur Urol 52 2007 798 803
32. A. Breda, E.G. Treat, and L. Haft-Candell Comparison of accuracy of 14-, 18- and 20-G needles in ex-vivo renal mass biopsy: a prospective, blinded study BJU Int 105 2009 940 945
33. R.H. Thompson, J.M. Kurta, and M. Kaag Tumor size is associated with malignant potential in renal cell carcinoma cases J Urol 181 2009 2033 2036
34. V.A. Sahni, A. Ly, and S.G. Silverman Usefulness of percutaneous biopsy in diagnosing benign renal masses that mimic malignancy Abdom Imaging 36 2011 91 101
35. M. Tsivian, V. Mouraviev, and D.M. Albala Clinical predictors of renal mass pathological features BJU Int 107 2011 735 740
36. I. Frank, M.L. Blute, J.C. Cheville, C.M. Lohse, A.L. Weaver, and H. Zincke Solid renal tumors: an analysis of pathological features related to tumor size J Urol 170 2003 2217 2220
37. I.S. Gill, S.F. Matin, and M.M. Desai Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients J Urol 170 2003 64 68
38. S. Choudhary, A. Rajesh, N.J. Mayer, K.A. Mulcahy, and A. Haroon Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms Clin Radiol 64 2009 517 522
39. A.B. Rosenkrantz, N. Hindman, E.F. Fitzgerald, B.E. Niver, J. Melamed, and J.S. Babb MRI features of renal oncocytoma and chromophobe renal cell carcinoma AJR Am J Roentgenol 195 2010 W421 W427
40. J.K. Kim, S.Y. Park, J.H. Shon, and K.S. Cho Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT Radiology 230 2004 677 684
41. I. Millet, F.C. Doyon, and D. Hoa Characterization of small solid renal lesions: can benign and malignant tumors be differentiated with CT? AJR Am J Roentgenol 197 2011 887 896
42. M. Remzi, D. Katzenbeisser, and M. Waldert Renal tumour size measured radiologically before surgery is an unreliable variable for predicting histopathological features: benign tumours are not necessarily small BJU Int 99 2007 1002 1006
43. S. Kawaguchi, K.A. Fernandes, A. Finelli, M. Robinette, N. Fleshner, and M.A. Jewett Most renal oncocytomas appear to grow: observations of tumor kinetics with active surveillance J Urol 186 2011 1218 1222
44. S.N. Chawla, P.L. Crispen, A.L. Hanlon, R.E. Greenberg, D.Y. Chen, and R.G. Uzzo The natural history of observed enhancing renal masses: meta-analysis and review of the world literature J Urol 175 2006 425 431
45. M.A.S. Jewett, K. Mattar, and J. Basiuk Active surveillance of small renal masses: progression patterns of early stage kidney cancer Eur Urol 60 2011 39 44
46. A.C. Mues, J.M. Palacios, and G. Haramis Contemporary experience in the management of angiomyolipoma J Endourol 24 2010 1883 1886
47. R.M. Seyam, N.K. Bissada, and S.A. Kattan Changing trends in presentation, diagnosis and management of renal angiomyolipoma: comparison of sporadic and tuberous sclerosis complex-associated forms Urology 72 2008 1077 1082
48. M. Remzi, and M. Marberger Renal tumor biopsies for evaluation of small renal tumors: why, in whom, and how? Eur Urol 55 2009 359 367
49. M.C. Smaldone, A. Kutikov, and B.L. Egleston Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis Cancer 118 2011 997 1006
50. J. Rothman, B. Egleston, Y.N. Wong, K. Iffrig, S. Lebovitch, and R.G. Uzzo Histopathological characteristics of localized renal cell carcinoma correlate with tumor size: a SEER analysis J Urol 181 2009 29 33 discussion 33-4
51. W.H. Chow, S.S. Devesa, J.L. Warren, and J.F. Fraumeni Jr. Rising incidence of renal cell cancer in the United States JAMA 281 1999 1628 1631
52. J.M. Hollingsworth, D.C. Miller, S. Daignault, and B.K. Hollenbeck Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis Cancer 109 2007 1763 1768
53. D.S. Arrontes, M.J. Acenero, J.I. Gonzales, M.M. Munoz, and P.P. Andres Survival analysis of clear cell renal carcinoma according to the Charlson Comorbidity Index J Urol 179 2008 857 861
54. B.R. Lane, R. Abouassaly, and T. Gao Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older Cancer 116 2010 3119 3126
55. J.M. Hollingsworth, D.C. Miller, S. Daignault, and B.K. Hollenbeck Rising incidence of small renal masses: a need to reassess treatment effect J Natl Cancer Inst 98 2006 1331 1334
56. A. Volpe, and M.A. Jewett The role of surveillance for small renal masses Nat Clin Pract Urol 4 2007 2 3
57. D.A. Kunkle, P.L. Crispen, D.Y. Chen, R.E. Greenberg, and R.G. Uzzo Enhancing renal masses with zero net growth during active surveillance J Urol 177 2007 849 853 discussion 853-4
58. V. Ficarra, G. Martignoni, and N. Maffei Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma Cancer 103 2005 68 75
59. J.C. Cheville, C.M. Lohse, H. Zincke, A.L. Weaver, and M.L. Blute Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma Am J Surg Pathol 27 2003 612 624
60. G. Novara, V. Ficarra, and A. Antonelli Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed? Eur Urol 58 2010 588 595
61. J.J. Patard, E. Leray, and N. Rioux-Leclercq Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience J Clin Oncol 23 2005 2763 2771
62. M. Remzi, M. Ozsoy, and H.C. Klingler Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter J Urol 176 2006 896 899
63. V. Ficarra, G. Novara, and S. Secco Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery Eur Urol 56 2009 786 793
64. J. Simhan, M.C. Smaldone, and K.J. Tsai Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy Eur Urol 60 2011 724 730
65. C.C. Kyle, M.S. Wingo, R.I. Carey, R.J. Leveillee, and V.G. Bird Diagnostic yield of renal biopsy immediately prior to laparoscopic radiofrequency ablation: a multicenter study J Endourol 22 2008 2291 2293
66. M. Aron, K. Kamoi, E. Remer, A. Berger, M. Desai, and I. Gill Laparoscopic renal cryoablation: 8-year, single surgeon outcomes J Urol 183 2010 889 895
67. C.R. Tracy, J.D. Raman, C. Donnally, C.K. Trimmer, and J.A. Cadeddu Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years Cancer 116 2010 3135 3142
68. H.C. Klingler, M. Marberger, J. Mauermann, M. Remzi, and M. Susani 'Skipping' is still a problem with radiofrequency ablation of small renal tumours BJU Int 99 2007 998 1001
69. P. Beemster, S. Phoa, H. Wijkstra, J. de la Rosette, and P. Laguna Follow-up of renal masses after cryosurgery using computed tomography; enhancement patterns and cryolesion size BJU Int 101 2008 1237 1242
70. S.L. Bolte, M.K. Ankem, and T.D. Moon Magnetic resonance imaging findings after laparoscopic renal cryoablation Urology 67 2006 485 489
71. M. Tsivian, C.Y. Kim, J.R. Caso, M.D. Rosenberg, R.C. Nelson, and T.J. Polascik Contrast enhancement on computed tomography after renal cryoablation: an evidence of treatment failure? J Endourol 26 2012 330 335
72. C.J. Weight, J.H. Kaouk, and N.J. Hegarty Correlation of radiographic imaging and histopathology following cryoablation and radio frequency ablation for renal tumors J Urol 179 2008 1277 1281 discussion 1281-3
73. K. Gupta, J.D. Miller, J.Z. Li, M.W. Russell, and C. Charbonneau Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review Cancer Treat Rev 34 2008 193 205
74. R.F. Sanchez-Ortiz, L.T. Madsen, and C.E. Bermejo A renal mass in the setting of a nonrenal malignancy: when is a renal tumor biopsy appropriate? Cancer 101 2004 2195 2201
75. Y. Allory, S. Culine, and A. de la Taille Kidney cancer pathology in the new context of targeted therapy Pathobiology 78 2011 90 98
76. A.R. Golshayan, S. George, and D.Y. Heng Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy J Clin Oncol 27 2009 235 241
77. E.J. Abel, S.H. Culp, and S.F. Matin Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: comparison with nephrectomy assessment J Urol 184 2010 1877 1881
78. B. Shuch, G. Bratslavsky, and J. Shih Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma BJU Int 109 2012 1600 1606
79. G.H. Mickisch, A. Garin, H. van Poppel, L. de Prijck, and R. Sylvester Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial Lancet 358 2001 966 970
80. R.C. Flanigan, S.E. Salmon, and B.A. Blumenstein Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer N Engl J Med 345 2001 1655 1659
81. T.K. Choueiri, A. Plantade, and P. Elson Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma J Clin Oncol 26 2008 127 131
82. J.P. Dutcher, P. de Souza, and D. McDermott Effect of temsirolimus versus interferon-alpha on outcome of patients with advanced renal cell carcinoma of different tumor histologies Med Oncol 26 2009 202 209
83. P. Schoffski, J.A. Garcia, and W.M. Stadler A phase II study of the efficacy and safety of AMG 102 in patients with metastatic renal cell carcinoma BJU Int 108 2011 679 686
84. B.K. Somani, G. Nabi, and P. Thorpe Image-guided biopsy-diagnosed renal cell carcinoma: critical appraisal of technique and long-term follow-up Eur Urol 51 2007 1289 1297 discussion 1296-7
85. E. Lechevallier, M. Andre, and D. Barriol Fine-needle percutaneous biopsy of renal masses with helical CT guidance Radiology 216 2000 506 510
86. A.A. Khan, I.S. Shergill, S. Quereshi, M. Arya, M.T. Vandal, and S.S. Gujral Percutaneous needle biopsy for indeterminate renal masses: a national survey of UK consultant urologists BMC Urol 7 2007 10
87. R.H. Breau, P.L. Crispen, S.M. Jenkins, M.L. Blute, and B.C. Leibovich Treatment of patients with small renal masses: a survey of the American Urological Association J Urol 185 2011 407 413
88. J.S. Lam, O. Shvarts, and J.W. Said Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma Cancer 103 2005 2517 2525
89. M. Waldert, T. Klatte, and A. Haitel Hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes Eur Urol 57 2010 661 666
90. I. Kümmerlin, F. ten Kate, and F. Smedts Core biopsies of renal tumors: a study on diagnostic accuracy, interobserver, and intraobserver variability Eur Urol 53 2008 1219 1227
91. Harris CR, Whitson JM, Meng MV. Under-grading of <4 cm renal masses on renal biopsy. BJU Int. In press. http://dx.doi.org/10.1111/j.1464-410X.2012. 10944.x.
92. M. Al Nazer, and W.A. Mourad Successful grading of renal-cell carcinoma in fine-needle aspirates Diagn Cytopathol 22 2000 223 226
93. V. Ficarra, M. Brunelli, and G. Novara Accuracy of on-bench biopsies in the evaluation of the histological subtype, grade, and necrosis of renal tumours Pathology 43 2011 149 155
94. B. Delahunt, D. Sika-Paotonu, and P.B. Bethwaite Fuhrman grading is not appropriate for chromophobe renal cell carcinoma Am J Surg Pathol 31 2007 957 960
95. C. Jeldres, M. Sun, and D. Liberman Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model? J Urol 182 2009 2585 2589
96. S. Gobbo, J.N. Eble, and G.T. Maclennan Renal cell carcinomas with papillary architecture and clear cell components: the utility of immunohistochemical and cytogenetical analyses in differential diagnosis Am J Surg Pathol 32 2008 1780 1786
97. G. Martignoni, M. Brunelli, and S. Gobbo Role of molecular markers in diagnosis and prognosis of renal cell carcinoma Anal Quant Cytol Histol 29 2007 41 49
98. M.H. Bui, D. Seligson, and K.R. Han Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy Clin Cancer Res 9 2003 802 811
99. C. Eichelberg, K. Junker, B. Ljungberg, and H. Moch Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability Eur Urol 55 2009 851 863
100. M.H. Roh, P. Dal Cin, S.G. Silverman, and E.S. Cibas The application of cytogenetics and fluorescence in situ hybridization to fine-needle aspiration in the diagnosis and subclassification of renal neoplasms Cancer Cytopathol 118 2010 137 145
101. D.A. Barocas, S. Mathew, and J.J. DelPizzo Renal cell carcinoma sub-typing by histopathology and fluorescence in situ hybridization on a needle-biopsy specimen BJU Int 99 2007 290 295
102. D.A. Barocas, S.M. Rohan, and J. Kao Diagnosis of renal tumors on needle biopsy specimens by histological and molecular analysis J Urol 176 2006 1957 1962
103. P.C. Rocca, M. Brunelli, and S. Gobbo Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study Mod Pathol 20 2007 722 728
104. A. Chyhrai, J. Sanjmyatav, and M. Gajda Multi-colour FISH on preoperative renal tumour biopsies to confirm the diagnosis of uncertain renal masses World J Urol 28 2010 269 274
105. M. Brunelli, B. Delahunt, and S. Gobbo Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses Am J Clin Pathol 133 2010 116 126
106. T. Klatte, D.B. Seligson, and J. LaRochelle Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy Cancer Epidemiol Biomarkers Prev 18 2009 894 900
107. M. Brunelli, A. Eccher, and S. Gobbo Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma Mod Pathol 21 2008 1 6
108. T. Klatte, P.N. Rao, and M. de Martino Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma J Clin Oncol 27 2009 746 753
109. X.J. Yang, J. Sugimura, and K.T. Schafernak Classification of renal neoplasms based on molecular signatures J Urol 175 2006 2302 2306
110. C.G. Rogers, J.A. Ditlev, and M.H. Tan Microarray gene expression profiling using core biopsies of renal neoplasia Am J Transl Res 1 2009 55 61
111. B.R. Lane, J. Li, and M. Zhou Differential expression in clear cell renal cell carcinoma identified by gene expression profiling J Urol 181 2009 849 860
112. T. Klatte, A.J. Pantuck, and J.W. Said Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma Clin Cancer Res 15 2009 1162 1169